US Stock MarketDetailed Quotes

PRLD Prelude Therapeutics

Watchlist
  • 3.850
  • -0.020-0.52%
Close May 31 16:00 ET
  • 3.850
  • 0.0000.00%
Post 16:03 ET
211.48MMarket Cap-2069P/E (TTM)

Prelude Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
17.96%34.34M
7.07%132.28M
11.96%37.38M
9.80%33.39M
9.97%32.4M
-3.87%29.12M
8.62%123.54M
1.14%33.39M
-1.39%30.41M
5.51%29.46M
Selling and administrative expenses
-4.77%6.93M
-5.76%28.88M
-6.24%7.05M
-5.23%7.12M
-8.82%7.43M
-2.49%7.28M
13.70%30.65M
-4.03%7.52M
-7.37%7.52M
47.85%8.15M
-General and administrative expense
-4.77%6.93M
-5.76%28.88M
-6.24%7.05M
-5.23%7.12M
-8.82%7.43M
-2.49%7.28M
13.70%30.65M
-4.03%7.52M
-7.37%7.52M
47.85%8.15M
Research and development costs
25.53%27.41M
11.31%103.39M
17.25%30.33M
14.73%26.26M
17.16%24.97M
-4.32%21.83M
7.04%92.89M
2.74%25.87M
0.74%22.89M
-4.90%21.31M
Operating profit
-17.96%-34.34M
-7.07%-132.28M
-11.96%-37.38M
-9.80%-33.39M
-9.97%-32.4M
3.87%-29.12M
-8.62%-123.54M
-1.14%-33.39M
1.39%-30.41M
-5.51%-29.46M
Net non-operating interest income expense
Other net income (expense)
108.45%2.91M
28.92%10.45M
-9.27%4.3M
519.87%2.78M
-5.75%1.97M
69.74%1.4M
296.96%8.1M
2,723.81%4.74M
200.67%448K
97.45%2.09M
Other non- operating income (expenses)
108.45%2.91M
28.92%10.45M
-9.27%4.3M
519.87%2.78M
-5.75%1.97M
69.74%1.4M
296.96%8.1M
2,723.81%4.74M
200.67%448K
97.45%2.09M
Income before tax
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
Income tax
Net income
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
Net income continuous Operations
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
Minority interest income
Net income attributable to the parent company
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
Basic earnings per share
27.59%-0.42
17.21%-2.02
21.67%-0.47
28.57%-0.45
6.90%-0.54
7.94%-0.58
-0.41%-2.44
15.49%-0.6
4.55%-0.63
0.00%-0.58
Diluted earnings per share
27.59%-0.42
17.21%-2.02
21.67%-0.47
28.57%-0.45
6.90%-0.54
7.94%-0.58
-0.41%-2.44
15.49%-0.6
4.55%-0.63
0.00%-0.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 17.96%34.34M7.07%132.28M11.96%37.38M9.80%33.39M9.97%32.4M-3.87%29.12M8.62%123.54M1.14%33.39M-1.39%30.41M5.51%29.46M
Selling and administrative expenses -4.77%6.93M-5.76%28.88M-6.24%7.05M-5.23%7.12M-8.82%7.43M-2.49%7.28M13.70%30.65M-4.03%7.52M-7.37%7.52M47.85%8.15M
-General and administrative expense -4.77%6.93M-5.76%28.88M-6.24%7.05M-5.23%7.12M-8.82%7.43M-2.49%7.28M13.70%30.65M-4.03%7.52M-7.37%7.52M47.85%8.15M
Research and development costs 25.53%27.41M11.31%103.39M17.25%30.33M14.73%26.26M17.16%24.97M-4.32%21.83M7.04%92.89M2.74%25.87M0.74%22.89M-4.90%21.31M
Operating profit -17.96%-34.34M-7.07%-132.28M-11.96%-37.38M-9.80%-33.39M-9.97%-32.4M3.87%-29.12M-8.62%-123.54M-1.14%-33.39M1.39%-30.41M-5.51%-29.46M
Net non-operating interest income expense
Other net income (expense) 108.45%2.91M28.92%10.45M-9.27%4.3M519.87%2.78M-5.75%1.97M69.74%1.4M296.96%8.1M2,723.81%4.74M200.67%448K97.45%2.09M
Other non- operating income (expenses) 108.45%2.91M28.92%10.45M-9.27%4.3M519.87%2.78M-5.75%1.97M69.74%1.4M296.96%8.1M2,723.81%4.74M200.67%448K97.45%2.09M
Income before tax -13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M2.38%-29.96M-1.89%-27.37M
Income tax
Net income -13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M2.38%-29.96M-1.89%-27.37M
Net income continuous Operations -13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M2.38%-29.96M-1.89%-27.37M
Minority interest income
Net income attributable to the parent company -13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M2.38%-29.96M-1.89%-27.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M2.38%-29.96M-1.89%-27.37M
Basic earnings per share 27.59%-0.4217.21%-2.0221.67%-0.4728.57%-0.456.90%-0.547.94%-0.58-0.41%-2.4415.49%-0.64.55%-0.630.00%-0.58
Diluted earnings per share 27.59%-0.4217.21%-2.0221.67%-0.4728.57%-0.456.90%-0.547.94%-0.58-0.41%-2.4415.49%-0.64.55%-0.630.00%-0.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.34%